#2020929
Iopconasól (F)
Ipconazole (F)
Iopconasól (F)
Ipconazole (F)
i gCuid A d’Iarscríbhinn III scriostar na colúin a bhaineann le déchlófop, fluaipioram, iopconasól agus tríbhúitiolaisín.
in Part A of Annex III, the columns for diclofop, fluopyram, ipconazole and terbuthylazine are deleted.
IOPCONASÓL
IPCONAZOLE
Iopconasól
Ipconazole
Dá bhrí sin, is iomchuí an formheas ar iopconasól a tharraingt siar.
It is therefore appropriate to withdraw the approval of ipconazole.
Tarraingítear siar an formheas ar an tsubstaint ghníomhach iopconasól.
The approval of the active substance ipconazole is withdrawn.
in Iarscríbhinn II, cuirtear isteach na colúin seo a leanas a bhaineann le déchlófop, fluaipioram, iopconasól agus tríbhúitiolaisín:
in Annex II, the following columns for diclofop, fluopyram, ipconazole and terbuthylazine are added:
Iopconasól (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-clóraibeinsil)-5-iseapróipil-1- (1H-1,2,4-tríasól-1-ilmeitil)cioglaipeantánól
Ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1- (1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
“iopconasól (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-clóraibeinsil)-5-iseapróipil-1- (1H-1,2,4-tríasól-1-ilmeitil)cioglaipeantánól
‘ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol
Iopconasól (ISO) (CAS RN 125225-28-7) ag a bhfuil íonacht 90 % nó níos mó de réir meáchain
Ipconazole (ISO) (CAS RN 125225-28-7) with a purity by weight of 90 % or more
Iopconasól (ISO) (CAS RN 125225-28-7) ag a bhfuil íonacht 90 % nó níos mó de réir meáchain
Ipconazole (ISO) (CAS RN 125225-28-7) with a purity by weight of 90 % or more
Ba cheart am leordhóthanach a thabhairt do na Ballstáit údaruithe le haghaidh táirgí cosanta plandaí ina bhfuil iopconasól a tharraingt siar.
Member States should be provided with sufficient time to withdraw authorisations for plant protection products containing ipconazole.
Déanfaidh na Ballstáit údaruithe le haghaidh táirgí cosanta plandaí ina bhfuil iopconasól a tharraingt siar mar shubstaint ghníomhach faoin 31 Lúnasa 2023.
Member States shall withdraw authorisations for plant protection products containing ipconazole as active substance by 31 August 2023.
Iopconasól (ISO) (CAS RN 125225-28-7) ag a bhfuil íonacht 90 % nó níos mó de réir meáchain
Ipconazole (ISO) (CAS RN 125225-28-7) with a purity by weight of 90 % or more
Rialachán (AE) 2021/618 ón gCoimisiún an 15 Aibreán 2021 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhar déchlófop, fluaipioram, iopconasól agus tríbhúitiolaisín i dtáirgí áirithe nó ar tháirgí áirithe (IO L 131, 16.4.2021, lch. 55).
Commission Regulation (EU) 2021/618 of 15 April 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for diclofop, fluopyram, ipconazole and terbuthylazine in or on certain products (OJ L 131, 16.4.2021, p. 55).
[2], iopconasól (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-clóraibeinsil)-5-iseapróipil-1-(1H-1,2,4-trí-asól-1-ilmeitil)cioglaipeantánól, bis(2-(2-meatocsai-eatocsa)eitil)éitear; teitriglím, 2-(4-treas- búitilbeinsil)próipianaildéad, taláit dé-iosochtaile, aicrioláit 2-meatocsai-eitile, sinc phiritióin; (T-4)-bis[1-(hiodrocsa-.capa.O)piridín-2(1H)-tianata.capa.S]sinc, fluaraclóradón (ISO); Is ón 1 Márta 2022 a bheidh feidhm ag 3-clóra-4-(clóraimeitil)-1-[3-(trífhluaraimeitil)feinil]pioróilidin-2-ón agus sárocsaíd bhis(α,α-démheitilibeinsil),
[2], ipconazole (ISO); (1RS,2SR,5RS;1RS,2SR,5SR)-2-(4-chlorobenzyl)-5-isopropyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, bis(2-(2-methoxyethoxy)ethyl)ether; tetraglyme, 2-(4-tert-butylbenzyl)propionaldehyde, diisooctyl phthalate, 2-methoxyethyl acrylate, pyrithione zinc; (T-4)-bis[1-(hydroxy-.kappa.O)pyridine-2(1H)-thionato-.kappa.S]zinc, flurochloridone (ISO); 3-chloro-4-(chloromethyl)-1-[3-(trifluoromethyl)phenyl]pyrrolidin-2-one and bis(α,α-dimethylbenzyl) peroxide shall apply from 1 March 2022,
Maidir leis na sonraí faireacháin a fuarthas i leith na sé shubstaint nó na sé ghrúpa substaintí eile ó bhí 2020 ann, is iad sin sulfaimeatocsasól, trímheitiprim, veanlafaicsín agus a mheitibilít O-deismeitilveanlafaicsín, an grúpa de 10 gcomhdhúil asóil (na hearraí cógaisíochta clóthrímhasól, fluconasól agus míoconasól agus na lotnaidicídí iomasailil, iopconasól, meataconasól, peanconasól, próclóras, teabúconasól agus teitreaconasól), na fuingicídí famocsadón agus démhocsastróibin, tháinig an Coimisiún ar an gconclúid ar bhonn na sonraí faireacháin sin nach fuarthas sonraí faireacháin ardcháilíochta leordhóthanacha agus, dá bhrí sin, gur cheart na substaintí sin nó na grúpaí substaintí sin a choimeád ar an liosta faire.
On the basis of the monitoring data obtained for the other six substances or groups of substances since 2020, namely sulfamethoxazole, trimethoprim, venlafaxine and its metabolite O-desmethylvenlafaxine, the group of ten azole compounds (the pharmaceuticals clotrimazole, fluconazole and miconazole and the pesticides imazalil, ipconazole, metconazole, penconazole, prochloraz, tebuconazole and tetraconazole) and the fungicides famoxadone and dimoxystrobin, the Commission concluded that insufficient high-quality monitoring data had been obtained, and that, therefore, those substances or groups of substances should remain on the watch list.
lena dtarraingítear siar an formheas ar an tsubstaint ghníomhach iopconasól i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle, lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún agus lena n-aisghairtear Rialachán Cur Chun Feidhme (AE) Uimh. 571/2014 ón gCoimisiún
withdrawing the approval of the active substance ipconazole in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, amending Commission Implementing Regulation (EU) No 540/2011 and repealing Commission Implementing Regulation (EU) No 571/2014
Le Rialachán Cur Chun Feidhme (AE) Uimh. 571/2014 ón gCoimisiún rinneadh iopconasól a fhormheas mar shubstaint ghníomhach i gcomhréir le Rialachán (CE) Uimh. 1107/2009 agus liostaíodh é i gCuid B den Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún.
Commission Implementing Regulation (EU) No 571/2014 approved ipconazole as an active substance in accordance with Regulation (EC) No 1107/2009 and listed it in Part B of the Annex to Commission Implementing Regulation (EU) No 540/2011.
An 9 Márta 2018 ghlac Coiste um Measúnú Riosca na Gníomhaireachta Eorpaí Ceimiceán tuairim i gcomhréir le hAirteagal 37(4) de Rialachán (CE) Uimh. 1272/2008 ó Pharlaimint na hEorpa agus ón gComhairle inar tháinig sé ar an gconclúid go gcomhlíonann iopconasól na critéir chun go n-aicmeofaí é mar shubstaint thocsaineach de chatagóir 1B, i measc critéir eile.
On 9 March 2018, the Committee for Risk Assessment of the European Chemicals Agency adopted an opinion in accordance with Article 37(4) of Regulation (EC) No 1272/2008 of the European Parliament and of the Council in which it concluded, amongst others, that ipconazole meets the criteria to be classified as toxic for reproduction category 1B.
Dá réir sin, le Rialachán Tarmligthe (AE) 2020/1182 ón gCoimisiún leasaíodh Iarscríbhinn VI a ghabhann le Rialachán (CE) Uimh. 1272/2008 agus aicmíodh iopconasól mar shubstaint thocsaineach le haghaidh an atáirgthe de chatagóir 1B.
Commission Delegated Regulation (EU) 2020/1182 consequently amended Annex VI to Regulation (EC) No 1272/2008 and classified ipconazole as toxic for reproduction category 1B.
I gcomhréir le hAirteagal 21(1) de Rialachán (CE) Uimh. 1107/2009, chuir an Coimisiún na Ballstáit, an tÚdarás agus an t-iarratasóir ar an eolas gur mheas sé go bhféadfadh sé nach gcomhlíonfar na critéir formheasa a leagtar síos in Airteagal 4(3), pointe (e)(ii) den Rialachán agus i bpointe 3.6.4 d’Iarscríbhinn II a ghabhann leis an Rialachán sin ós rud é gur sainaithníodh riosca fadtéarmach d’éin agus go n-aicmítear iopconasól mar shubstaint thocsaineach le haghaidh an atáirgthe de chatagóir 1B.
In accordance with Article 21(1) of Regulation (EC) No 1107/2009, the Commission informed the Member States, the Authority and the applicant that it considered the approval criteria laid down in Article 4(3), point (e)(ii), of that Regulation and in point 3.6.4 of Annex II to that Regulation may no longer be met given that a high long-term risk to birds was identified and ipconazole is classified as toxic for reproduction category 1B.
D’iarr an Coimisiún ar an iarratasóir a bharúlacha a chur isteach maidir leis an ráiteas ón Údarás agus maidir leis an togra uaidh an formheas ar iopconasól a tharraingt siar de bharr na n-ábhar imní a shainaithin an tÚdarás.
The Commission invited the applicant to submit its comments on the statement of the Authority and on its proposal to withdraw the approval of ipconazole due to the concerns identified by the Authority.
Measann an Coimisiún nach gcomhlíonann iopconasól na critéir formheasa a thuilleadh a leagtar síos in Airteagal 4(3), pointe (e)(ii) de Rialachán (CE) Uimh. 1107/2009 agus i bpointe 3.6.4 d’Iarscríbhinn II a ghabhann leis an Rialachán sin.
The Commission considers that ipconazole no longer fulfils the criteria for approval laid down in Article 4(3), point (e)(ii), of Regulation (EC) No 1107/2009 and in point 3.6.4 of Annex II to that Regulation.
Maidir le táirgí cosanta plandaí ina bhfuil iopconasól, i gcás ina ndeonóidh na Ballstáit aon tréimhse chairde i gcomhréir le hAirteagal 46 de Rialachán (CE) Uimh. 1107/2009, ba cheart an tréimhse sin a bheith chomh gearr agus is féidir agus gan bheith níos faide ná 9 mí ó dháta theacht i bhfeidhm an Rialacháin seo.
For plant protection products containing ipconazole, where Member States grant any grace period in accordance with Article 46 of Regulation (EC) No 1107/2009, that period should be as short as possible and expire no later than 9 months from the date of entry into force of this Regulation.
Leis an Rialachán seo, ní chuirtear cosc ar iarratas nua a chur isteach maidir leis an tsubstaint ghníomhach iopconasól a fhormheas de bhun Airteagal 7 de Rialachán (CE) Uimh. 1107/2009.
This Regulation does not prevent the submission of a new application for the approval of ipconazole pursuant to Article 7 of Regulation (EC) No 1107/2009.
Rialachán Cur Chun Feidhme (AE) Uimh. 571/2014 ón gCoimisiún an 26 Bealtaine 2014 lena bhformheastar an tsubstaint ghníomhach iopconasól, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 ón gCoimisiún (IO L 157, 27.5.2014, lch. 96).
Commission Implementing Regulation (EU) No 571/2014 of 26 May 2014 approving the active substance ipconazole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 157, 27.5.2014, p. 96).
[Ráiteas maidir leis an athbhreithniú ar fhormheas na substainte gníomhaí iopconasól.] EFSA Journal [Iris EPSA] 2022;20(8):7133. https://doi.org/10.2903/j.efsa.2022.7296.
EFSA Journal 2022;20(8):7133, https://doi.org/10.2903/j.efsa.2022.7133
Technical report on the outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for ipconazole in light of confirmatory data. [Tuarascáil theicniúil ar thoradh an chomhairliúcháin leis na Ballstáit, leis an iarratasóir agus le EFSA maidir leis an measúnú riosca lotnaidicídí ar iopconasól i bhfianaise na sonraí deimhniúcháin].
Technical report on the outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for ipconazole in light of confirmatory data.
Rialachán Cur Chun Feidhme (AE) 2020/1295 ón gCoimisiún an 16 Meán Fómhair 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) 2015/408 a mhéid a bhaineann leis na substaintí gníomhacha cairbeataimíd, eimimeictin, fluraclóradón, gáma-ciahalaitrin, halasulfúrón-meitil, iopconasól agus teambaitrí-ón a áireamh sa liosta substaintí a bhféadfaí ionadú a dhéanamh orthu, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2020/1295 of 16 September 2020 amending Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substances carbetamide, emamectin, flurochloridone, gamma-cyhalothrin, halosulfuron-methyl, ipconazole and tembotrione in the list of candidates for substitution is to be incorporated into the EEA Agreement.
Rialachán Cur Chun Feidhme (AE) 2020/2007 an 8 Nollaig 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 maidir le síneadh a chur le tréimhsí ceadaithe na substaintí gníomhacha 1-deacánól, 1,4-démheitiolnaftailéin, 6-beinsioladainín, aicéacuinicil, Adoxophyes orana granulovirus, sulfáit alúmanaim, aimíosulbróm, Aureobasidium pullulans (tréithchineálacha DSM 14940 agus DSM 14941), asadaraictin, Bacillus pumilus QST 2808, beanalacsail-M, bicsifein, búipireamáit, tréithchineál O de Candida oleophila, clórantrainileapról, fosfónáit déshóidiam, déthianón, dóidín, eimimeictin, fluibeindé-aimíde, fluaimeatúrón, flucsaipiorocsad, flutríafól, heicsitiasocs, iomasamocs, iopconasól, iosocsaibein, L-aigéad ascorbach, sulfar aoil, ola oráiste, tréithchineál FE 9901 Paecilomyces fumosoroseus, peindémheatailin, peanfluifein, peintiaipiorad, fosfónáití déshóidiam, prósulfúrón, tréithchineál DSMZ 13134 Pseudomonas sp, pireadailil, pirióifeanón, piorocsulam, cuinmeireac, aigéad S-scoiteach, seadacsán, sintifein, tiasulfáit airgid sóidiam, spineatoram, spiriteitreamat, tréithchineál WYEC 108 Streptomyces lydicus, tó-fluvailionáit, teabúifeanóisíd, teambaitrí-ón, tíoncarbasón, vailifeanaláit, foisfíd since (IO L 414, 9.12.2020, lch. 10).
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide (OJ L 414, 9.12.2020, p. 10).
Rialachán Cur Chun Feidhme (AE) 2020/2007 an 8 Nollaig 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le fadú thréimhsí formheasa na substaintí gníomhacha 1-deacánól, 1,4-démheitiolnaftailéin, 6-beinsioladainín, aicéacuinicil, Adoxophyes orana granulovirus, sulfáit alúmanaim, aimíosulbróm, Aureobasidium pullulans (tréithchineálacha DSM 14940 agus DSM 14941), asadaraictin, Bacillus pumilus QST 2808, beanalacsail-M, bicsifein, búipireamáit, Candida oleophila tréithchineál O, clórantrainileapról, fosfónáit déshóidiam, déthianón, dóidín, eimimeictin, fluibeindé-aimíd, fluaimeatúrón, flucsaipiorocsad, flutríafól, heicsitiasocs, iomasamocs, iopconasól, iosocsaibein, aigéad L-ascorbach, sulfar aoil, ola oráiste, Paecilomyces fumosoroseus tréithchineál FE 9901, peindémheatailin, peanfluifein, peintiaipiorad, fosfónáití déshóidiam, prósulfúrón, Pseudomonas sp. tréithchineál DSMZ 13134, pireadailil, pirióifeanón, piorocsulam, cuinmeireac, aigéad S-scoiteach, seadacsán, sintifein, tiasulfáit airgid sóidiam, spíonatóram, spiriteitreamat, Streptomyces lydicus tréithchineál WYEC 108, tó-fluvailionáit, teabúifeanóisíd, teambaitrí-ón, tíoncarbasón, vailifeanaláit, foisfíd since (IO L 414, 9.12.2020, lch. 10).
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide (OJ L 414, 9.12.2020, p. 10).
Rialachán Cur Chun Feidhme (AE) 2020/2007 ón gCoimisiún an 8 Nollaig 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh thréimhsí formheasa na substaintí gníomhacha 1-deacánól, 1,4-démheitiolnaftailéin, 6-beinsioladainín, aicéacuinicil, Adoxophyes orana granulovirus, sulfáit alúmanaim, aimíosulbróm, Aureobasidium pullulans (tréithchineálacha DSM 14940 agus DSM 14941), asadaraictin, Bacillus pumilus QST 2808, beanalacsail-M, bicsifein, búipireamáit, Candida oleophila tréithchineál O, clórantrainileapról, fosfónáit déshóidiam, déthianón, dóidín, eimimeictin, fluibeindé-aimíd, fluaimeatúrón, flucsaipiorocsad, flutríafól, heicsitiasocs, iomasamocs, iopconasól, iosocsaibein, aigéad L-ascorbach, sulfar aoil, ola oráiste, Paecilomyces fumosoroseus tréithchineál FE 9901, peindémheatailin, peanfluifein, peintiaipiorad, fosfónáití déshóidiam, prósulfúrón, Pseudomonas sp. tréithchineál DSMZ 13134, pireadailil, pirióifeanón, piorocsulam, cuinmeireac, aigéad S-scoiteach, seadacsán, sintifein, tiasulfáit airgid sóidiam, spíonatóram, spiriteitreamat, Streptomyces lydicus tréithchineál WYEC 108, tó-fluvailionáit, teabúifeanóisíd, teambaitrí-ón, tíoncarbasón, vailifeanaláit, foisfíd since (IO L 414, 9.12.2020, lch. 10).
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide (OJ L 414, 9.12.2020, p. 10).
Rialachán Cur Chun Feidhme (AE) 2020/2007 ón gCoimisiún an 8 Nollaig 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 1,4-démheitiolnaftailéin, 6-beinsioladainín, aicéacuinicil, Adoxophyes orana granulovirus, sulfáit alúmanaim, aimíosulbróm, Aureobasidium pullulans (tréithchineálacha DSM 14940 agus DSM 14941), asadaraictin, Bacillus pumilus QST 2808, beanalacsail-M, bicsifein, búipireamáit, Candida oleophila tréithchineál O, clórantrainileapról, fosfónáit déshóidiam, déthianón, dóidín, eimimeictin, fluibeindé-aimíd, fluaimeatúrón, flucsaipiorocsad, flutríafól, heicsitiasocs, iomasamocs, iopconasól, iosocsaibein, aigéad L-ascorbach, sulfar aoil, ola oráiste, Paecilomyces fumosoroseus tréithchineál FE 9901, peindémheatailin, peanfluifein, peintiaipiorad, fosfónáití déshóidiam, prósulfúrón, Pseudomonas sp. tréithchineál DSMZ 13134, pireadailil, pirióifeanón, piorocsulam, cuinmeireac, aigéad S-scoiteach, seadacsán, sintifein, tiasulfáit airgid sóidiam, spíonatóram, spiriteitreamat, Streptomyces lydicus tréithchineál WYEC 108, tó-fluvailionáit, teabúifeanóisíd, teambaitrí-ón, tíoncarbasón, vailifeanaláit, foisfíd since (IO L 414, 9.12.2020, lch. 10).
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide (OJ L 414, 9.12.2020, p. 10).
Rialachán Cur Chun Feidhme (AE) 2020/2007 ón gCoimisiún an 8 Nollaig 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 1-deacánól, 1,4-dé-mheitiolnaftailéin, 6-beinsioladainín, aicéacuinicil, Adoxophyes orana granulovirus, sulfáit alúmanaim, aimíosulbróm, Aureobasidium pullulans (tréithchineálacha DSM 14940 agus DSM 14941), asadaraictin, Bacillus pumilus QST 2808, beanalacsail-M, bicsifein, búipireamáit, Candida oleophila tréithchineál O, clórantrainileapról, fosfónáit déshóidiam, déthianón, dóidín, eimimeictin, fluibeindé-aimíd, fluaimeatúrón, flucsaipiorocsad, flutríafól, heicsitiasocs, iomasamocs, iopconasól, iosocsaibein, aigéad L-ascorbach, sulfar aoil, ola oráiste, Paecilomyces fumosoroseus tréithchineál FE 9901, peindémheatailin, peanfluifein, peintiaipiorad, fosfónáití déshóidiam, prósulfúrón, Pseudomonas sp. tréithchineál DSMZ 13134, pireadailil, pirióifeanón, piorocsulam, cuinmeireac, aigéad S-scoiteach, seadacsán, sintifein, tiasulfáit airgid sóidiam, spíonatóram, spiriteitreamat, Streptomyces lydicus tréithchineál WYEC 108, tó-fluvailionáit, teabúifeanóisíd, teambaitrí-ón, tíoncarbasón, vailifeanaláit, foisfíd since, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2020/2007 of 8 December 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 1,4-dimethylnaphthalene, 6-benzyladenine, acequinocyl, Adoxophyes orana granulovirus, aluminium sulfate, amisulbrom, Aureobasidium pullulans (strains DSM 14940 and DSM 14941), azadirachtin, Bacillus pumilus QST 2808, benalaxyl-M, bixafen, bupirimate, Candida oleophila strain O, chlorantraniliprole, disodium phosphonate, dithianon, dodine, emamectin, flubendiamide, fluometuron, fluxapyroxad, flutriafol, hexythiazox, imazamox, ipconazole, isoxaben, L-ascorbic acid, lime sulphur, orange oil, Paecilomyces fumosoroseus strain FE 9901, pendimethalin, penflufen, penthiopyrad, potassium phosphonates, prosulfuron, Pseudomonas sp. strain DSMZ 13134, pyridalyl, pyriofenone, pyroxsulam, quinmerac, S-abscisic acid, sedaxane, sintofen, sodium silver thiosulfate, spinetoram, spirotetramat, Streptomyces lydicus strain WYEC 108, tau-fluvalinate, tebufenozide, tembotrione, thiencarbazone, valifenalate, zinc phosphide is to be incorporated into the EEA Agreement.